Regulatory and Quality Management Services for the Pharmaceutical Industry
ELS Group is an international pharmaceutical consultancy specializing in regulatory and quality management services, with integrated operations in Europe and Latin America.
We operate throughout the entire lifecycle of regulated products, from initial strategic definition to post-market maintenance, supporting companies operating in complex, multi-jurisdictional, and high-risk regulatory environments.
ELS Group's Performance in Regulatory and Quality Services by Segment
ELS Group’s regulatory and quality management services are organized into specialized solutions, allowing each company to directly access the area most relevant to its context.
Each solution delves into specific technical requirements, regulatory strategies, and deliverables for the segment.
Regulatory and Quality Management Services for Medical Devices
A solution dedicated to companies that develop, manufacture, or market medical devices and need to operate in compliance with regulatory and quality requirements in different markets.
Regulatory and Quality Management Services for Medicines
Designed for pharmaceutical companies at different stages of development and commercialization, this solution integrates regulatory strategy, quality assurance, medical record keeping, surveillance, and market access.
Regulatory and Quality Management Services for Cosmetics
A service that caters to companies involved in the development, registration, and marketing of cosmetic products in regulated markets.
Regulatory and Quality Management Services for Food and Supplements
Ideal for companies that work with food supplements and related products, this solution integrates regulatory requirements, quality, and product safety.
Regulatory and Quality Management Services for Medicinal Cannabidiol
Regulatory and quality performance in one of the most sensitive and regulated environments in the healthcare industry.
Regulatory and Quality Management Services for Cleaning Products
This solution caters to companies that work with cleaning products and products subject to specific sanitary controls.
Regulatory and Quality Management Services for Companies
Designed for organizations that need to structure or strengthen their regulatory and quality areas, this solution focuses on creating systems, processes, and strategies tailored to the reality of the business.
The structure behind the Regulatory and Quality Management Services of the ELS Group
ELS Group’s regulatory and quality management services are structured for companies that need to operate in complex regulatory environments with multiple jurisdictions, high technical requirements, and low risk appetite.
ELS Group’s positioning in regulatory and quality management services is supported by differentiators that are not common in the market:
- Operational presence in 11 countries
- Local and international Regulatory Affairs and Quality teams
- Active participation of group experts in regulatory bodies, technical committees, and sectoral councils.
- Development and use of proprietary systems, including advanced cybersecurity layers.
- Portfolio of quality certifications, many of them private.
- First company to conduct the registration of medicinal cannabis in Portugal.
- Advanced technical positioning in ISO 13485, with our own approach (ISO factor 13485)
These factors allow ELS Group to act not only as a consultant, but as an extended regulatory framework for the client.
Certifications, benchmarks and quality systems
ELS Group works with the main regulatory and quality benchmarks required by the most rigorous national and international markets, structuring solutions according to the product profile, the market, and the competent authority. Its activities include, among others:
- Quality Management Systems applicable to medical devices and healthcare.
- Approaches aligned with ISO 13485, including proprietary advanced models.
- Good practices applicable to manufacturing, distribution, laboratory and surveillance.
- Integration between regulatory requirements and quality systems.
This approach ensures that regulatory and quality management services are not an operational cost, but a pillar of regulatory trust.
Regulatory agencies with which the ELS Group works
ELS Group is an international pharmaceutical consulting firm specializing in regulatory and quality management services, with a consolidated presence in Europe and Latin America.
With a presence in 11 countries, the group works in an integrated manner with local and international regulatory authorities, supporting companies in the interpretation, application, and maintenance of regulatory requirements throughout the entire product lifecycle.
Its work with regulatory agencies is not limited to the submission of applications, but involves technical dialogue, continuous monitoring, and strategic alignment with the regulatory expectations of each market.
Regulatory agencies with which ELS Group works:
Argentina — ANMAT (National Administration of Medicines, Food and Medical Technology)
The authority responsible for regulating and overseeing medicines, medical devices, food, and products subject to health surveillance in Argentina.
Brazil — ANVISA (National Health Surveillance Agency)
Regulatory body responsible for medicines, medical devices, food, cosmetics, sanitizing products and health products, with a strong impact on quality requirements, surveillance and post-market.
Chile — ANAMED (National Medicines Agency)
The entity responsible for regulating medicines and pharmaceutical products in Chile, acting in the evaluation of quality, safety, and efficacy.
Colombia — INVIMA (National Institute of Medicines and Food Surveillance)
Regulatory agency that oversees medicines, medical devices, food and cosmetics, playing a central role in health surveillance and quality control.
Mexico — COFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios)
The health authority responsible for regulating and inspecting health-related products and services, including medicines, medical devices, and food.
Europe — EMA (European Medicines Agency)
The agency responsible for the scientific evaluation, supervision, and monitoring of drug safety in the European Union, serving as a reference for multinational regulatory strategies.
Portugal — INFARMED (National Authority for Medicines and Health Products, I.P.)
The national authority responsible for regulating medicines, medical devices and health products in Portugal, with a strong focus on technical evaluation and surveillance.
Portugal - DGAV (General Directorate of Food and Veterinary Medicine)
The authority responsible for regulation and oversight in the areas of food safety and animal health in Portugal. It operates in sanitary control, inspection, and product compliance, ensuring adherence to local regulatory requirements.
France — ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)
The agency responsible for the safety, quality, and efficacy of medicines and health products in the French market.
Spain — AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)
Regulatory body that oversees medicines, medical devices and sanitary products, acting in regulation, control and surveillance.
United Kingdom — MHRA (Medicines and Healthcare products Regulatory Agency)
The authority responsible for regulating medicines and health products in the United Kingdom, with a central role after Brexit in defining its own regulatory strategies.
Italy — AIFA (Agenzia Italiana del Farmaco)
Italian regulatory agency responsible for medicines, including quality assessment, safety, efficacy and market access aspects.
Germany — BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
The federal institute responsible for regulating medicines and medical devices in Germany, with a strong focus on technical evaluation and post-market surveillance.
Why integrate Regulation and Quality into a single strategy?
Separating regulation and quality may seem functional in the short term, but it creates fragility in the medium and long term. When these areas do not operate in an integrated manner, documentary inconsistencies, rework, and greater exposure to regulatory risks arise.
ELS Group’s regulatory and quality management services were designed precisely to avoid this scenario, creating coherent, auditable systems aligned with the expectations of health authorities and the market.
With a global presence, recognized technical authority, and integrated operations, ELS Group supports companies that need to operate with safety, predictability, and excellence in highly regulated markets.
Frequently asked questions about regulatory and quality management services.
What are regulatory and quality management services in the pharmaceutical industry?
Regulatory and quality management services encompass all activities that ensure products, processes, and operations comply with the requirements of health authorities and the quality systems applicable to each market.
In the pharmaceutical and healthcare industry, these services are fundamental to ensuring safety, efficacy, traceability, and regulatory predictability throughout the entire product lifecycle, from development to post-market.
When does a company need these services?
A company needs these services whenever it operates in regulated environments or intends to do so.
This includes situations such as launching new products, registration processes, participating in audits and inspections, seeking certifications, adapting to new sanitary regulations, or expanding to other countries.
The sooner these services are structured, the lower the regulatory risk and rework tend to be in the future.
In which countries does the ELS Group operate?
ELS Group operates internationally, with a presence in 11 countries, offering regulatory and quality support in Europe and Latin America.
The company has specialized local teams that work in an integrated manner with the main regulatory authorities in each region, allowing it to align global strategies with the specific regulatory requirements of each market.
How do regulatory and quality services support international expansion?
These services allow companies to align technical requirements, documentation, and quality systems with the demands of different countries.
This helps the company reduce regulatory barriers, avoid rework, and gain predictability when entering new markets. ELS Group’s international presence facilitates this process by integrating local knowledge with a global strategic vision.
What is ISO 13485 and why is it important for medical devices?
ISO 13485 is the international standard that establishes requirements for quality management systems applicable to medical devices throughout their entire life cycle.
It is fundamental to ensuring that products are developed, manufactured, and maintained in a safe, traceable manner, and in accordance with the regulatory requirements of major international markets.
How does ELS Group support companies in implementing ISO 13485?
ELS Group supports companies in structuring, implementing, and maintaining quality management systems aligned with ISO 13485, always considering the type of device, the stage of development, and the target markets.
Our work goes beyond documentary compliance, focusing on functional, auditable systems integrated with the company’s regulatory strategy.